Delivery Order SPE2DP23D0004-SPE2DP24F7574

Award Date 9/5/24
Potential Completion Date 2/27/25
Potential Value $16M
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,201,021.80 firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. This delivery order is part of two larger Indefinite Delivery Contracts (IDCs) awarded to Valneva...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a potential value of $3,203,200.00 and a completion date of January 19, 2024. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, has received numerous prime federal contract awards, primarily from the Defense Logistics...
This is a firm fixed-price delivery order awarded by the Bureau of Medical Services, a civilian agency, to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The order is for the supply of the IXIARO Japanese encephalitis vaccine, with an ultimate completion date of September 30, 2024 and a ceiling value of $56,646.00. The contract was issued under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule...
This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE, by the Medical Supply Chain division of the U.S. Department of Defense. The $5,883,494.40 contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a period of performance ending on July 31, 2025. Valneva USA, Inc. serves as the prime contractor and is responsible for vaccine production and delivery, primarily from its Potomac, Maryland...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide the IXIARO Japanese encephalitis virus vaccine. The $247,897.00 firm fixed price delivery order was placed against Valneva's GSA Schedule 61 contract for Pharmaceuticals and Drugs. The delivery order has a completion date of March 15, 2022 and was awarded on February 15, 2022. This order is part of Valneva's broader...
This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc. (dba Intercell USA Inc.), a foreign-owned for-profit organization. The $18,760.75 order is for the supply of the Japanese encephalitis vaccine IXIARO, which is being delivered against Valneva USA's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. This order has an ultimate completion date of...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $148,200.00 firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the IXIARO vaccine. Valneva USA is a subsidiary of the French specialty vaccine company Valneva SE. The contract has no set-aside designation and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The IXIARO vaccine is used to protect against...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The $4,079,706.40 contract is for the delivery of Japanese encephalitis vaccines to a location in Maryland, with a completion date of November 9, 2018. This delivery order is part of a larger indefinite-delivery/indefinite-quantity (ID/IQ) contract vehicle that Valneva USA holds with the...
  • SPE2DP23D0004
    Indefinite Delivery Contract
  • SPE2DP23D0004-SPE2DP24F7574
    Delivery Order

This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical countermeasures program. The contract does not have a set-aside designation. Valneva USA is the prime contractor, and the place of performance is Bethesda, Maryland. The contract has a period of performance running through February 27, 2025.

Generated 12/5/24, 9:34 AM